Recent R&D Highlights
- 6 Downloads
Among the more interesting presentations at the 18th International Diabetes Federation Congress held in Paris, France, in August 2003, were two focused on a needle-free delivery method for insulin and a new approach to the management of type 2 diabetes mellitus.
Breathe Easy – Inhaled Insulin is on the Way
The administration of insulin by inhalation offers advantages over injected insulin beyond the obvious benefit of needle-free delivery, according to studies presented at the meeting. In a phase III study, Exubera® (inhaled insulin) provided improved glycemic control and greater patient satisfaction, compared with Avandia® (rosiglitazone), while a second study showed that administration by inhalation provided more consistent exposure to insulin than SC delivery, resulting in more even control of plasma glucose levels.
Needle-free the way of the future
Speaking at a symposium entitled “Insulin: what have they done to you?”, Dr Lutz Heinemann from the Profil Institute for Metabolic...